Artiva Biotherapeutics share#snapshot#suffix 136429208 / US04317A1079
6.94
USD
0.14
USD
2.12 %
09.10.2026
BTT
| prices + charts + realtime | news + analysis | fundamental | company | corresponding shares | action | |
|---|---|---|---|---|---|---|
| price + Chart | chart (large) | news + ad-hoc | balance sheet/p&l | fixed dates | certificates | portfolio#add_instrument_to#depot |
| times + sale | chart comparison | analysis | detailnavigation#shares#estimates | profile | portfolio#add_instrument_to#watchlist | |
| stock exchange | realtime push | stock price appreciation potential | dividend/annual shareholders' meeting | |||
| historic | analysis | |||||
prices + charts + realtime
news + analysis
fundamental
company
corresponding shares
Artiva Biotherapeutics Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2025 | Artiva Biotherapeutics Inc Registered Shs | 0.00 | 0.00 | USD |
| 2024 | Artiva Biotherapeutics Inc Registered Shs | 0.00 | 0.00 | USD |
| 2023 | Artiva Biotherapeutics Inc Registered Shs | - | - | USD |
| 2022 | Artiva Biotherapeutics Inc Registered Shs | - | - | USD |
| 2021 | Artiva Biotherapeutics Inc Registered Shs | - | - | USD |
| 2020 | Artiva Biotherapeutics Inc Registered Shs | - | - | USD |
| 2019 | Artiva Biotherapeutics Inc Registered Shs | - | - | USD |
share#balance#profitpershare- Artiva Biotherapeutics
| -3.4 25 | -5.8 24 | -8.2 23 | -17.5 22 | -23.9 21 | -6.5 20 | -1.5 19 |
share#balance#salespershare- Artiva Biotherapeutics
| 0 25 | 0.0 24 | 1.4 23 | 0.2 22 | 0.1 21 | 0 20 | 0 19 |
share#balance#p_e_ratio- Artiva Biotherapeutics
Artiva Biotherapeutics Inc Registered Shs: share#balance#headline#theshare (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (berichtet) | -3.43 | -5.81 | -8.16 | -17.48 | -23.88 | -6.50 | -1.49 |
| Gewinn je Aktie (unverwässert) | -3.43 | -2.69 | -1.18 | -2.42 | -4.08 | -1.02 | -0.23 |
| Gewinn je Aktie (verwässert) | -3.43 | -2.69 | -1.18 | -2.42 | -4.08 | -1.02 | -0.23 |
| Dividende je Aktie | 0.00 | 0.00 | - | - | - | - | - |
| Veränderung Dividende je Aktie in % | - | - | - | - | - | - | - |
| share#balance#cell#dividend_payment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Artiva Biotherapeutics Inc Registered Shs: share#balance#business_ratio (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales_share | 0.00 | 0.01 | 1.38 | 0.20 | 0.11 | 0.00 | 0.00 |
| KGV (Jahresendkurs, Gewinn unverwässert) | - | - | - | - | - | - | - |
| KGV (Jahresendkurs, Gewinn verwässert) | - | - | - | - | - | - | - |
| share#balance#cell#dividend_ratio | 0.00 | 0.00 | - | - | - | - | - |
| share#balance#cell#equity_ratio | 81.72 | 89.05 | 51.75 | 56.91 | 75.07 | -73.77 | -81.84 |
| share#balance#cell#debt_ratio | 18.28 | 10.95 | 48.25 | 43.09 | 24.93 | 173.77 | 181.84 |
Artiva Biotherapeutics Inc Registered Shs: share#balance#headline#income_statement (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| share#balance#cell#sales | 0.00 | 0.25 | 33.49 | 4.93 | 2.00 | 0.00 | 0.00 |
| share#balance#cell#sales_change | -100.00 | -99.25 | 579.21 | 146.30 | - | - | - |
| share#balance#cell#sales_gross_profit | -2.60 | -2.18 | 31.23 | 3.77 | 1.75 | -0.07 | -0.01 |
| share#balance#cell#sales_gross_profit_change | -19.13 | - | 727.62 | 115.11 | - | -565.14 | - |
| share#balance#cell#operating_income | -90.61 | -68.08 | -30.67 | -59.83 | -53.27 | -18.27 | -3.13 |
| share#balance#cell#operating_income_change | -33.09 | -121.98 | 48.74 | -12.31 | -191.57 | -483.74 | - |
| share#balance#cell#income_before_tax | -83.87 | -65.37 | -28.65 | -58.74 | -71.83 | -17.99 | -3.99 |
| share#balance#cell#income_before_tax_change | -28.29 | -128.19 | 51.22 | 18.22 | -299.23 | -351.24 | - |
| share#balance#cell#income_after_tax | -83.87 | -65.37 | -28.72 | -58.79 | -71.83 | -17.99 | -3.99 |
| share#balance#cell#income_after_tax_change | -28.29 | -127.62 | 51.15 | 18.15 | -299.23 | -351.24 | - |
Artiva Biotherapeutics Inc Registered Shs: share#balance#headline#balance (in Mio. USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Fremdkapital | 25 | 23 | 51 | 57 | 42 | 51 | 9 |
| Langzeit Gesamtverbindlichk. je Aktie | 0.47 | 0.44 | 1.58 | 1.80 | 1.31 | 2.56 | 0.45 |
| share#balance#cell#total_equity | 110 | 187 | 54 | 76 | 128 | -22 | -4 |
| share#balance#cell#total_equity_change | -41.08 | - | -15.15 | -58.34 | -312.01 | -444.62 | - |
| share#balance#cell#total_liabilities_and_equity | 135 | 210 | 105 | 133 | 170 | 29 | 5 |
| share#balance#cell#total_liabilities_and_equity_change | -35.79 | 99.38 | -21.00 | -21.70 | 481.26 | 504.13 | - |
Artiva Biotherapeutics Inc Registered Shs: share#balance#headline#other_data (in USD)
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | -3.43 | -2.69 | -1.18 | -2.42 | -4.08 | -1.02 | -0.23 |
| Veränderung Gewinn je Aktie (unverwässert) in % | -27.49 | -127.59 | 51.15 | 40.74 | -299.22 | -351.15 | - |
| Gewinn je Aktie (verwässert) | -3.43 | -2.69 | -1.18 | -2.42 | -4.08 | -1.02 | -0.23 |
| Veränderung Gewinn je Aktie (verwässert) in % | -27.49 | -127.59 | 51.15 | 40.74 | -299.22 | -351.15 | - |
| share#balance#cell#employees | 104 | 89 | 77 | - | 43 | 25 | - |
| share#balance#cell#employees_change | 16.85 | 15.58 | - | - | 72.00 | - | - |
Artiva Biotherapeutics Inc Registered Shs Termine
| Unternehmen | Event | Datum |
|---|---|---|
| Artiva Biotherapeutics Inc Registered Shs | Quartalszahlen | 18.11.2026 |
| Artiva Biotherapeutics Inc Registered Shs | Quartalszahlen | 29.03.2027 |
| Artiva Biotherapeutics Inc Registered Shs | Quartalszahlen | 07.05.2027 |
| Artiva Biotherapeutics Inc Registered Shs | Quartalszahlen | 12.08.2027 |
Artiva Biotherapeutics Inc Registered Shs vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Hauptversammlung | Annual General Meeting | 08.09.2026 |
| Quartalszahlen | Q2 2026 Earnings Release | 06.08.2026 |
| Quartalszahlen | Q1 2026 Earnings Release | 08.05.2026 |
| Quartalszahlen | Q4 2025 Earnings Release | 10.03.2026 |
| Quartalszahlen | Q3 2025 Earnings Release | 12.11.2025 |
| Quartalszahlen | Q2 2025 Earnings Release | 06.08.2025 |
| Hauptversammlung | Annual General Meeting | 24.06.2025 |
| Quartalszahlen | Q1 2025 Earnings Release | 08.05.2025 |
| Quartalszahlen | Q4 2024 Earnings Release | 24.03.2025 |
| Quartalszahlen | Q3 2024 Earnings Release | 12.11.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 29.08.2024 |
share#companyprofile#balance#staff#headline
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#employees | 0 | 25 | 43 | 0 | 77 |
| share#companyprofile#balance#staff#salesperemployee | 0.00 | 0.00 | 0.05 | 0.00 | 0.43 |
Bilanz (in Mio. USD) - Aktiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#currentassets | 2 | 26 | 162 | 105 | 80 |
| share#companyprofile#balance#staff#fixedassets | 3 | 3 | 8 | 28 | 25 |
| share#companyprofile#balance#staff#totalassets | 5 | 29 | 170 | 133 | 105 |
Bilanz (in Mio. USD) - Passiva
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| share#companyprofile#balance#staff#totalborrowing | 9 | 51 | 42 | 57 | 51 |
| share#companyprofile#balance#staff#totalequity | -4 | -22 | 128 | 76 | 54 |
| share#companyprofile#balance#staff#totalliabilities | 5 | 29 | 170 | 133 | 105 |